In defence of science-based regulation FREE

Henry Miller

J Commer Biotechnol 13: 65-67; doi:10.1057/palgrave.jcb.3050046

Abstract | Full Text | PDF

Critical success factors for biotechnology industry in Canada

Sandra Vanderbyl and Sherry Kobelak

J Commer Biotechnol 13: 68-77; doi:10.1057/palgrave.jcb.3050042

Abstract | Full Text | PDF

New path to profits in biotech: Taking the acquisition exit FREE

Nils Behnke and Norbert Hültenschmidt

J Commer Biotechnol 13: 78-85; doi:10.1057/palgrave.jcb.3050045

Abstract | Full Text | PDF

Is anyone listening?

David C Ireland, Craig Cormick and Damian Hine

J Commer Biotechnol 13: 86-98; doi:10.1057/palgrave.jcb.3050043

Abstract | Full Text | PDF

Decision-making associated with drug candidates in the biotechnology research and development (R&D) pipeline FREE

Grant H Skrepnek and Jeff J Sarnowski

J Commer Biotechnol 13: 99-110; doi:10.1057/palgrave.jcb.3050040

Abstract | Full Text | PDF

ApaTech: A biomaterials success story

Simon Cartmell

J Commer Biotechnol 13: 111-119; doi:10.1057/palgrave.jcb.3050047

Abstract | Full Text | PDF

Dyslipidaemia: Focus shifts from LDL-C to HDL-C

Duncan Emerton

J Commer Biotechnol 13: 120-124; doi:10.1057/palgrave.jcb.3050039

Abstract | Full Text | PDF

Legal and regulatory update

J Commer Biotechnol 13: 125-134; doi:10.1057/palgrave.jcb.3050037

Abstract | Full Text | PDF

Innovation and Entrepreneurship in Biotechnology, an International Perspective: Concepts, Theories and Cases

Simon Shohet

J Commer Biotechnol 13: 135-136; doi:10.1057/palgrave.jcb.3050044

Abstract | Full Text | PDF

International Trade and Policies for Genetically Modified Products

Thomas Kowalski

J Commer Biotechnol 13: 137; doi:10.1057/palgrave.jcb.3050041

Abstract | Full Text | PDF